Debulking Does Not Improve Survival in Multiorgan Mets CRC

Source link :

CHICAGO — Tumor debulking does not improve survival in multiorgan metastatic colorectal cancer (CRC), according to a phase 3 trial presented at the American Society of Clinical Oncology (ASCO) 2024 annual meeting. The trial findings revealed that adding tumor debulking to standard first-line palliative systemic therapy failed to boost progression-free or overall survival across nearly […]

Author : News Health

Publish date : 2024-06-11 09:53:32

Copyright for syndicated content belongs to the linked Source.